NYSE - Delayed Quote
USD
Cardinal Health, Inc. (CAH)
247.18
-1.43
(-0.58%)
At close: September 4 at 4:00:02 PM EDT
248.47
+1.29
(+0.52%)
After hours: September 4 at 7:56:46 PM EDT
Trade CAH on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for CAH
What's happening with CAH?
Powered by Yahoo ScoutCardinal Health (CAH) is experiencing a pivotal shift towards specialty pharmaceuticals, although recent earnings missed expectations. The company announced a $5 billion share buybackand continues to see steady growth in its generics business, contributing to overall profitability.
Powered by Yahoo Scout
- Previous Close
248.61 - Open
246.34 - Bid 247.19 x 40000
- Ask 250.73 x 20000
- Day's Range
246.41 - 249.29 - 52 Week Range
145.87 - 258.30 - Volume
1,543,542 - Avg. Volume
2,158,133 - Market Cap (intraday)
57.488B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
34.38 - EPS (TTM)
7.19 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield 2.06 (0.83%)
- Ex-Dividend Date Oct 1, 2026
- 1y Target Est
270.94
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
CAH
21.14%
S&P 500 (^GSPC)
12.75%
1-Year Return
CAH
67.24%
S&P 500 (^GSPC)
18.71%
3-Year Return
CAH
195.63%
S&P 500 (^GSPC)
70.93%
5-Year Return
CAH
413.84%
S&P 500 (^GSPC)
70.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/2/2026
-
Market Cap
57.10B
-
Enterprise Value
61.13B
-
Trailing P/E
33.95
-
Forward P/E
19.53
-
PEG Ratio (5yr expected)
1.23
-
Price/Sales (ttm)
0.23
-
Price/Book (mrq)
--
-
Enterprise Value/Revenue
0.24
-
Enterprise Value/EBITDA
17.57
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.67%
-
Return on Assets (ttm)
3.72%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
254.25B
-
Net Income Avi to Common (ttm)
1.71B
-
Diluted EPS (ttm)
7.19
Balance Sheet and Cash Flow
-
Total Cash (mrq)
4.86B
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
4.75B
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Continued growth across all segments
Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its PSS segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The GMPD segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has more than 55,000 employees. The shares are a component of the S&P 500.
RatingPrice Target -
The major stock indices are all higher at midday on Friday, setting the stage
The major stock indices are all higher at midday on Friday, setting the stage for what appears to be a positive end to what has been a difficult week. Meanwhile, Bitcoin continues to enjoy a mini-Renaissance - up over 7% today and 23% over the past five days, but still down about 12% for the year to date. Over the course of the week, investors have been faced with ongoing earnings reports from major retailers, but attention has been hijacked at least to a degree by rising Treasury yields. And then there is the ongoing but arguably stalled conflict in the Middle East, where investors and the world at large are contemplating an apparent new phase that the White House is calling 'economic warfare.' What that will be and what impact it will have is an unknown. But as is always the case with unknowns, any form of uncertainty is not helpful in the eyes of Wall Street.
-
Daily – Vickers Top Buyers & Sellers for 08/21/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Cardinal Health Earnings: Revenue Slowdown on Highlight but Earnings Power Still Exceptional
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
RatingPrice Target
